Polymer Factory (publ) is thrilled to announce the launch of its new website. The new website has been designed with the primary goal of offering a user-friendly experience with improved navigation to allow customers to see Polymer Factory’s full portfolio of products and learn more about their underlying technology and potential. 

In addition, the Investors section has been upgraded to make it easier for investors to find relevant information about the company and its activities.

CEO Elin Mignérus:

"Our website is a large part of our identity, and today Polymer Factory launched the new website after a period of reworking the profile. Being a central part to our interface with customers and the presentation of our products, the new website is a step in strengthening the company’s brand."

Polymer Factory invites visitors to explore the new website; keep up to date on our latest press releases, highlights, and company announcements in our News section. We hope you enjoy the new look!

About Polymer Factory

Polymer Factory was founded in 2006 at KTH Royal Institute of Technology and its Board of Directors have been essential in driving dendritic nanotechnology research to commercialization for almost 15 years – expertise that has been transferred to the Company’s products. Emerging from many years of cutting-edge research within the field, Polymer Factory today has, in the Company’s assessment, the world’s largest product portfolio of dendritic materials with customers ranging from Big Pharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. Polymer Factory has also used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments.

For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com

Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.